Vaginal inserted estradiol pharmaceutical compositions and methods
US10398708B2 · kind B2 · utility
18Cited by
572References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 9, 2018 |
| Grant date | Sep 3, 2019 |
| Priority date | — |
| Expiry date | Feb 9, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In one aspect, compositions and methods for the treatment of vulvovaginal atrophy (VVA) are provided. In one embodiment, the method comprises administering an estrogen to a subject having VVA by inserting a dosage form comprising a liquid pharmaceutical composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.